365 related articles for article (PubMed ID: 11708424)
1. Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors.
Detora LM; Krupa D; Bolognese J; Sperling RS; Ehrich EW
J Rheumatol; 2001 Nov; 28(11):2494-503. PubMed ID: 11708424
[TBL] [Abstract][Full Text] [Related]
2. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis.
Ehrich EW; Davies GM; Watson DJ; Bolognese JA; Seidenberg BC; Bellamy N
J Rheumatol; 2000 Nov; 27(11):2635-41. PubMed ID: 11093446
[TBL] [Abstract][Full Text] [Related]
3. Precision of composite measures of osteoarthritis efficacy in comparison to that of individual endpoints.
Bolognese JA; Ehrich EW; Schnitzer TJ
J Rheumatol; 2001 Dec; 28(12):2700-4. PubMed ID: 11764220
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies.
Schnitzer TJ; Weaver AL; Polis AB; Petruschke RA; Geba GP;
J Rheumatol; 2005 Jun; 32(6):1093-105. PubMed ID: 15940774
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies.
Birbara C; Ruoff G; Sheldon E; Valenzuela C; Rodgers A; Petruschke RA; Chang DJ; Tershakovec AM
Curr Med Res Opin; 2006 Jan; 22(1):199-210. PubMed ID: 16393445
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee.
Schnitzer TJ; Kivitz AJ; Lipetz RS; Sanders N; Hee A
Arthritis Rheum; 2005 Dec; 53(6):827-37. PubMed ID: 16342089
[TBL] [Abstract][Full Text] [Related]
7. Effect of rofecoxib therapy on measures of health-related quality of life in patients with osteoarthritis.
Ehrich EW; Bolognese JA; Watson DJ; Kong SX
Am J Manag Care; 2001 Jun; 7(6):609-16. PubMed ID: 11439734
[TBL] [Abstract][Full Text] [Related]
8. Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trial.
Gibofsky A; Williams GW; McKenna F; Fort JG
Arthritis Rheum; 2003 Nov; 48(11):3102-11. PubMed ID: 14613272
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials.
Katz N; Ju WD; Krupa DA; Sperling RS; Bozalis Rodgers D; Gertz BJ; Gimbel J; Coleman S; Fisher C; Nabizadeh S; Borenstein D;
Spine (Phila Pa 1976); 2003 May; 28(9):851-8; discussion 859. PubMed ID: 12941996
[TBL] [Abstract][Full Text] [Related]
10. Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies.
Smugar SS; Schnitzer TJ; Weaver AL; Rubin BR; Polis AB; Tershakovec AM
Curr Med Res Opin; 2006 Jul; 22(7):1353-67. PubMed ID: 16834834
[TBL] [Abstract][Full Text] [Related]
11. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
Kivitz A; Ma C; Ahdieh H; Galer BS
Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
[TBL] [Abstract][Full Text] [Related]
12. Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group.
Cannon GW; Caldwell JR; Holt P; McLean B; Seidenberg B; Bolognese J; Ehrich E; Mukhopadhyay S; Daniels B
Arthritis Rheum; 2000 May; 43(5):978-87. PubMed ID: 10817549
[TBL] [Abstract][Full Text] [Related]
13. Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study Group.
Ehrich EW; Schnitzer TJ; McIlwain H; Levy R; Wolfe F; Weisman M; Zeng Q; Morrison B; Bolognese J; Seidenberg B; Gertz BJ
J Rheumatol; 1999 Nov; 26(11):2438-47. PubMed ID: 10555907
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement.
Tubach F; Ravaud P; Baron G; Falissard B; Logeart I; Bellamy N; Bombardier C; Felson D; Hochberg M; van der Heijde D; Dougados M
Ann Rheum Dis; 2005 Jan; 64(1):29-33. PubMed ID: 15208174
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee.
Karlsson J; Pivodic A; Aguirre D; Schnitzer TJ
J Rheumatol; 2009 Jun; 36(6):1290-7. PubMed ID: 19411388
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal antiinflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial.
Emkey R; Rosenthal N; Wu SC; Jordan D; Kamin M;
J Rheumatol; 2004 Jan; 31(1):150-6. PubMed ID: 14705234
[TBL] [Abstract][Full Text] [Related]
17. Steroid injection for osteoarthritis of the hip: a randomized, double-blind, placebo-controlled trial.
Lambert RG; Hutchings EJ; Grace MG; Jhangri GS; Conner-Spady B; Maksymowych WP
Arthritis Rheum; 2007 Jul; 56(7):2278-87. PubMed ID: 17599747
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state.
Tubach F; Ravaud P; Baron G; Falissard B; Logeart I; Bellamy N; Bombardier C; Felson D; Hochberg M; van der Heijde D; Dougados M
Ann Rheum Dis; 2005 Jan; 64(1):34-7. PubMed ID: 15130902
[TBL] [Abstract][Full Text] [Related]
19. Management of osteoarthritis (OA) with an unsupervised home based exercise programme and/or patient administered assessment tools. A cluster randomised controlled trial with a 2x2 factorial design.
Ravaud P; Giraudeau B; Logeart I; Larguier JS; Rolland D; Treves R; Euller-Ziegler L; Bannwarth B; Dougados M
Ann Rheum Dis; 2004 Jun; 63(6):703-8. PubMed ID: 15140778
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee.
Niethard FU; Gold MS; Solomon GS; Liu JM; Unkauf M; Albrecht HH; Elkik F
J Rheumatol; 2005 Dec; 32(12):2384-92. PubMed ID: 16331769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
